Lanean...
Treatment Failure With Atorvastatin After Change From Rosuvastatin to Atorvastatin
Lipid levels remained largely unchanged, and patients experienced few adverse events following the conversion of patients from rosuvastatin to atorvastatin therapy at the Huntington VAMC.
Gorde:
| Argitaratua izan da: | Fed Pract |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontline Medical Communications Inc.
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6366311/ https://ncbi.nlm.nih.gov/pubmed/30766036 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|